1. Home
  2. ARCT vs WLDN Comparison

ARCT vs WLDN Comparison

Compare ARCT & WLDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • WLDN
  • Stock Information
  • Founded
  • ARCT 2013
  • WLDN 1964
  • Country
  • ARCT United States
  • WLDN United States
  • Employees
  • ARCT N/A
  • WLDN N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • WLDN Military/Government/Technical
  • Sector
  • ARCT Health Care
  • WLDN Consumer Discretionary
  • Exchange
  • ARCT Nasdaq
  • WLDN Nasdaq
  • Market Cap
  • ARCT 320.8M
  • WLDN 1.6B
  • IPO Year
  • ARCT N/A
  • WLDN 2006
  • Fundamental
  • Price
  • ARCT $18.06
  • WLDN $102.07
  • Analyst Decision
  • ARCT Strong Buy
  • WLDN Strong Buy
  • Analyst Count
  • ARCT 10
  • WLDN 2
  • Target Price
  • ARCT $50.88
  • WLDN $111.50
  • AVG Volume (30 Days)
  • ARCT 499.7K
  • WLDN 452.1K
  • Earning Date
  • ARCT 11-06-2025
  • WLDN 10-30-2025
  • Dividend Yield
  • ARCT N/A
  • WLDN N/A
  • EPS Growth
  • ARCT N/A
  • WLDN 94.22
  • EPS
  • ARCT N/A
  • WLDN 2.39
  • Revenue
  • ARCT $122,122,000.00
  • WLDN $628,172,000.00
  • Revenue This Year
  • ARCT N/A
  • WLDN N/A
  • Revenue Next Year
  • ARCT $28.92
  • WLDN $9.00
  • P/E Ratio
  • ARCT N/A
  • WLDN $42.04
  • Revenue Growth
  • ARCT N/A
  • WLDN 13.82
  • 52 Week Low
  • ARCT $8.04
  • WLDN $30.43
  • 52 Week High
  • ARCT $25.88
  • WLDN $121.00
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 54.73
  • WLDN 51.36
  • Support Level
  • ARCT $17.38
  • WLDN $96.14
  • Resistance Level
  • ARCT $18.69
  • WLDN $106.22
  • Average True Range (ATR)
  • ARCT 0.86
  • WLDN 5.07
  • MACD
  • ARCT -1.05
  • WLDN -1.44
  • Stochastic Oscillator
  • ARCT 96.76
  • WLDN 37.07

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About WLDN Willdan Group Inc.

Willdan Group Inc is a provider of professional technical and consulting services to utilities, private industry, and public agencies at all levels of government. It operates in the business segments of Energy and Engineering and Consulting. It generates the majority of its revenue from the Energy segment, which includes services such as audit and surveys, program design, master planning, benchmarking analysis, design engineering, construction management, performance contracting, installation, advances in software and data analytics, and other services. All of its revenue is derived from the domestic markets.

Share on Social Networks: